Age disparities in clinical trials of poly (ADP-ribose) polymerase (PARP) inhibitors in patients with high grade serous ovarian cancer: A wake up call to improving outcomes in older patients

J Geriatr Oncol. 2025 Jan;16(1):102152. doi: 10.1016/j.jgo.2024.102152. Epub 2024 Nov 12.
No abstract available

Keywords: Clinical trials; Older patients; Ovarian cancer.